Animal models of insulin-dependent diabetes
- PMID: 15286387
- DOI: 10.1385/1-59259-805-6:195
Animal models of insulin-dependent diabetes
Abstract
Animal models have contributed enormously to study in the field of type 1 diabetes. Perhaps the most intensively studied model is the nonobese diabetic (NOD) mouse, which develops an autoimmune-mediated spontaneous diabetes associated with the development of insulin autoantibodies and insulitis. Accurate measurement of antiislet autoantibodies by radioassay and detection of antigen-specific T cells using major histocompatibility complex tetramers are possible. Various strategies have been developed in preventing diabetes in animal models; a peptide-induced model of type 1 diabetes has been described. Finally, the development of peptide vaccines is hampered by the risk of anaphylaxis in both mouse and humans. In this chapter, methods and strategies to measure antiinsulin autoantibodies, to detect antigen-specific T cells by tetramer analysis, and to prevent diabetes using peptide vaccines are discussed. Along with these topics, a protocol of peptide-induced diabetes and peptide vaccine-induced anaphylaxis are described, serving as a reminder of the potential dangers that could exist in human trials. In summary, animal models have become necessary in the study of type 1 diabetes and provide researchers important tools to conduct studies that could not otherwise be performed in humans.
Similar articles
-
Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.Eur J Immunol. 1995 Oct;25(10):2851-7. doi: 10.1002/eji.1830251021. Eur J Immunol. 1995. PMID: 7589082
-
One amino acid difference is critical for suppression of the development of experimental autoimmune diabetes (EAD) with intravenous injection of insulinB:9-23 peptide.Biochem Biophys Res Commun. 2008 Sep 26;374(3):581-6. doi: 10.1016/j.bbrc.2008.07.066. Epub 2008 Jul 21. Biochem Biophys Res Commun. 2008. PMID: 18647597
-
Genetic differentiation of poly I:C from B:9-23 peptide induced experimental autoimmune diabetes.J Autoimmun. 2004 Jun;22(4):307-13. doi: 10.1016/j.jaut.2004.01.006. J Autoimmun. 2004. PMID: 15120754
-
Insulin-specific tolerance in diabetes.Clin Immunol. 2002 Jan;102(1):2-11. doi: 10.1006/clim.2001.5142. Clin Immunol. 2002. PMID: 11781061 Review.
-
Insulin--a primary autoantigen in type 1 diabetes?Trends Mol Med. 2005 Oct;11(10):445-8. doi: 10.1016/j.molmed.2005.08.005. Trends Mol Med. 2005. PMID: 16150642 Review.
Cited by
-
2011 Update: antigen-specific therapy in type 1 diabetes.Curr Opin Endocrinol Diabetes Obes. 2011 Aug;18(4):235-40. doi: 10.1097/MED.0b013e32834803ae. Curr Opin Endocrinol Diabetes Obes. 2011. PMID: 21844706 Free PMC article. Review.
-
Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes.Curr Diab Rep. 2015 Dec;15(12):113. doi: 10.1007/s11892-015-0689-z. Curr Diab Rep. 2015. PMID: 26458384 Free PMC article. Review.
-
Autoimmune polyglandular syndromes.Nat Rev Endocrinol. 2010 May;6(5):270-7. doi: 10.1038/nrendo.2010.40. Epub 2010 Mar 23. Nat Rev Endocrinol. 2010. PMID: 20309000 Review.
-
Targeting the trimolecular complex: the pathway towards type 1 diabetes prevention.Diabetes Technol Ther. 2013 Jun;15 Suppl 2(Suppl 2):S2-8-S2-12. doi: 10.1089/dia.2013.0114. Diabetes Technol Ther. 2013. PMID: 23786298 Free PMC article.
-
Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.Diabetes Care. 2009 Oct;32(10):1753-68. doi: 10.2337/dc09-0373. Diabetes Care. 2009. PMID: 19794001 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical